Get the Stockscreener App
6.52
0.91%
-0.06
After Hours:
6.52
Immucell Corp stock is traded at $6.52, with a volume of 6,102.
It is down -0.91% in the last 24 hours and up +10.14% over the past month.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
See More
Previous Close:
$6.58
Open:
$6.79
24h Volume:
6,102
Relative Volume:
0.46
Market Cap:
$58.98M
Revenue:
$23.84M
Net Income/Loss:
$-3.81M
P/E Ratio:
-13.04
EPS:
-0.5
Net Cash Flow:
$-713.00K
1W Performance:
+1.09%
1M Performance:
+10.14%
6M Performance:
+18.55%
1Y Performance:
+82.63%
1-Day Range:
$6.52
$6.99
1-Week Range:
$6.50
$6.99
52-Week Range:
$3.38
$7.60
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.52 | 59.52M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immucell Corp Stock (ICCC) Latest News
Will ImmuCell Corporation continue its uptrendPortfolio Risk Summary & Daily Entry Point Alerts - newser.com
Live market analysis of ImmuCell CorporationJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
Detecting price anomalies in ImmuCell Corporation with AI2025 Technical Overview & Fast Entry High Yield Stock Tips - newser.com
The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne - sharewise.com
ImmuCell's (ICCC) "Hold (C-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Best data tools to analyze ImmuCell Corporation stockQuarterly Profit Summary & Precise Buy Zone Identification - newser.com
Developing predictive dashboards with ImmuCell Corporation dataWeekly Earnings Recap & Proven Capital Preservation Tips - newser.com
Why ImmuCell Corporation (IUL) stock is listed among top recommendationsJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
What is the fair value estimate for ImmuCell Corporation (IUL) stock in 2025July 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Calculating The Fair Value Of ImmuCell Corporation (NASDAQ:ICCC) - Yahoo Finance
Is ImmuCell Corporation stock a dividend growth opportunity2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Is ImmuCell Corporation a good long term investmentCandlestick Pattern Analysis & Get The Analyst Consensus With One Click - earlytimes.in
Is a relief rally coming for ImmuCell Corporation holdersTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
ImmuCell names Olivier te Boekhorst as new president and CEO - Investing.com
ImmuCell Announces Selection of its Next President and CEO - MarketScreener
ImmuCell Corporation Appoints Olivier te Boekhorst as President, Effective November 1, 2025 - MarketScreener
Technical analysis overview for ImmuCell Corporation stock2025 Performance Recap & Entry Point Strategy Guides - newser.com
What indicators show strength in ImmuCell Corporation2025 Volatility Report & Consistent Growth Stock Picks - newser.com
Chart overlay techniques for tracking ImmuCell CorporationMarket Growth Summary & Technical Pattern Based Signals - newser.com
ImmuCell (NASDAQ:ICCC) Share Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Published on: 2025-09-20 13:32:32 - خودرو بانک
Real time alert setup for ImmuCell Corporation performance2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Stock Analysis: Does ImmuCell Corporation have a sustainable dividend2025 Macro Impact & Verified Entry Point Detection - خودرو بانک
What candlestick patterns are forming on ImmuCell CorporationShort Setup & Real-Time Chart Breakout Alerts - newser.com
Investment Review: Will ImmuCell Corporation benefit from AI trendsEarnings Growth Summary & Weekly High Return Stock Opportunities - khodrobank.com
Investment Recap: Is ImmuCell Corporation a speculative investmentPortfolio Update Report & Consistent Profit Alerts - خودرو بانک
Is ImmuCell Corporation still worth holding after the dip2025 Short Interest & Growth Focused Entry Point Reports - newser.com
Smart tools for monitoring ImmuCell Corporation’s price actionMarket Rally & Reliable Breakout Forecasts - newser.com
Predicting ImmuCell Corporation trend using moving averagesTrend Reversal & Capital Protection Trade Alerts - newser.com
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Does ImmuCell Corporation show high probability of reboundJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com
Aug PreEarnings: Will ImmuCell Corporation benefit from geopolitical trendsQuarterly Market Summary & Precise Swing Trade Entry Alerts - خودرو بانک
Weekly Trades: Is ImmuCell Corporation vulnerable to short sellersRate Hike & Weekly Breakout Opportunity Watchlist - خودرو بانک
Revenue Check: Is ImmuCell Corporation forming a bullish divergenceWeekly Gains Report & Technical Buy Zone Confirmations - خودرو بانک
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):